Login

Urban biodiversity | Severin Weig, CEO, Ciments du Maroc SACMA:CAS 00:10:00

Share On Facebook Share On Twitter

Severin Weig is the ceo and MD of Ciments Du Maroc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Born in Seattle and covering the West Coast|Yoko Okano,Founding Partner,First Row Partners
00:10:00
A consistent approach applying a disciplined strategy|MARC VINAGRAY, Senior Associate,Pomona Capital
00:10:00
Leapfrogging offers a strategic advantage by bypassing traditional developmental stages to adopt newer, more advanced technologies or practices, yielding faster progress and competitive edge.
00:10:00
Navigating the Choppy Waters of AI: Opportunities and Risks Ahead
00:10:00
Discover BR Properties' BROF11 Fund with Martin Jaco|CEO , BR Properties SA
00:10:00
In Conversation: Leadership in Technology and Innovation - Sir Kenneth Olisa OBE, Chairman of Restoration Partners
00:10:00
Facing Economic Challenges: Germany's Resilience and Adaptation | Manfred Knof , CEO ,  Commerzbank.
00:10:00
Mutares Investment Strategy and Financial Outlook with Johannes Laumann | Johannes Laumann , CIO, Mutares.
00:10:00
Stone Harbor focuses on maintaining its coastal resilience and environmental preservation while managing community services. Key initiatives include beach nourishment projects, safeguarding beach-nesting birds, and ensuring the safety of the water supply.
00:10:00
The Jason Sissel Matter: 2023 Robert M. Dell Prize for Extraordinary Public Service | Dana Latham - Founder of Latham & Watkins
00:10:00
Investing in the Age of Social Media: 6 Lessons from Today's Media Diet with Christian Newton | Brent Kessel - Founder & Financial Advisor of Abacus Wealth Partners
00:10:00
Tracy Rees, President and CEO of Intrinsyc, discusses the company's focus on Qualcomm's Snapdragon platform and addresses the challenges faced by designers in the development process.|Tracy Rees, President and CEO of Intrinsyc

© 2017 - Neuhu+